Antimutagenic activity of fluphenazine in short-term tests

K Gasiorowski1, B Brokos, K Szyba

  • 1Department of Basic Medical Sciences, Wrocłlaw Medical University, 14 Kochanowskiego Str., 51-601 Wrocłlaw, Poland. kaz@basmed.am.wroc.pl

Mutagenesis
|January 6, 2001
PubMed

Insights

Fluphenazine, an antipsychotic, demonstrated antimutagenic properties by reducing genotoxicity in various tests. This phenothiazine derivative also lowered free radical levels, suggesting a key mechanism for its protective effects against mutagens.

Area of Science:

  • Pharmacology
  • Genetics
  • Toxicology

Background:

  • Fluphenazine is a phenothiazine antipsychotic.
  • Genotoxicity is a major concern in drug development and exposure.
  • Understanding drug mechanisms against mutagens is crucial.

Purpose of the Study:

  • To evaluate the antimutagenic potential of fluphenazine.
  • To investigate the effect of fluphenazine on genotoxicity induced by various mutagens.
  • To explore the role of free radical reduction in fluphenazine's action.

Main Methods:

  • Ames test with direct and indirect mutagens.
  • Short-term tests on human lymphocytes (micronucleus assay, thioguanine resistance, sister chromatid exchange).
  • In vitro assessment of free radical levels in human granulocytes.

Main Results:

  • Fluphenazine reduced genotoxicity in the Ames test.
  • The strongest inhibitory effects were observed in the micronucleus assay and thioguanine resistance test.
  • Fluphenazine significantly decreased free radical levels in human granulocytes.

Conclusions:

  • Fluphenazine exhibits significant antimutagenic activity.
  • It can potentially prevent genotoxicity from specific mutagens like daunorubicin and benzo[a]pyrene.
  • Free radical scavenging is a likely mechanism underlying fluphenazine's protective effects.

Related Concept Videos

Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...